SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-398800
Filing Date
2012-09-21
Accepted
2012-09-20 20:19:05
Documents
4
Period of Report
2012-09-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d414688d8k.htm 8-K 15214
2 PRESS RELEASE d414688dex991.htm EX-99.1 8983
3 GRAPHIC g414688g62i98.jpg GRAPHIC 4477
4 GRAPHIC g414688g83e49.jpg GRAPHIC 2093
  Complete submission text file 0001193125-12-398800.txt   34855
Mailing Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9
Business Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 121102969
SIC: 2834 Pharmaceutical Preparations